Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020876082> ?p ?o ?g. }
- W2020876082 endingPage "1438" @default.
- W2020876082 startingPage "1434" @default.
- W2020876082 abstract "Weight gain is a major side effect of antipsychotic treatment. Some atypical antipsychotic agents have profound effects on weight. Body weight is regulated by a complex system, including both peripheral and central factors. Two of the hormones that seem to play an important role in the regulation of food intake, energy metabolism, and body weight are leptin and ghrelin. Leptin is a mediator of long-term regulation of energy balance, suppressing food intake and thereby inducing weight loss. Ghrelin on the other hand is a fast-acting hormone, seemingly playing a role in meal initiation. In this present study it is aimed to compare the effects of five different atypical antipsychotic medications on leptin and ghrelin. 112 patients who were treated either with clozapine (n = 20), olanzapine (n = 28), risperidone (n = 22), quetiapine (n = 20) or amisulpride (n = 22) as monotherapy for at least one year and age, gender, and body mass index (BMI) matched control group (n = 23) were assessed cross-sectionally. Ghrelin and leptin levels were measured with enzyme-immunoassay. When fasting serum leptin levels were compared between groups, control group had the highest mean value (9.2 ± 6.7) and amisulpride group had the lowest mean value (3.7 ± 2.1) but still there was no statistically significant difference between six groups (F = 1993, p = 0.084). In the comparison of the mean values of fasting serum ghrelin levels there was a statistically significant difference between groups (F = 11,473, p = 0.00). In post-hoc analysis it was seen that the control group had the lowest ghrelin level (194.5 ± 86.8). Quetiapine treated group (378.1 ± 260.4) had similar fasting serum ghrelin levels to control group. All the other antipsychotic treatment groups had significantly higher levels of fasting serum ghrelin compared to control group, highest in amisulpride treated group (597.0 ± 150.0). The weight-gain side effect of atypical antipsychotics can be related with the orexigenic effect of elevated serum ghrelin rather than leptin deficit. Among the five widely used atypical antipsychotics quetiapine is the only one which does not elevate the ghrelin level." @default.
- W2020876082 created "2016-06-24" @default.
- W2020876082 creator A5012639651 @default.
- W2020876082 creator A5045766928 @default.
- W2020876082 creator A5046589366 @default.
- W2020876082 creator A5071471123 @default.
- W2020876082 creator A5086305216 @default.
- W2020876082 date "2008-08-01" @default.
- W2020876082 modified "2023-10-06" @default.
- W2020876082 title "Effects of second generation antipsychotics on leptin and ghrelin" @default.
- W2020876082 cites W1616806865 @default.
- W2020876082 cites W1969777837 @default.
- W2020876082 cites W1973960214 @default.
- W2020876082 cites W1995523980 @default.
- W2020876082 cites W2000226432 @default.
- W2020876082 cites W2007011095 @default.
- W2020876082 cites W2027427622 @default.
- W2020876082 cites W2038500073 @default.
- W2020876082 cites W2042826217 @default.
- W2020876082 cites W2047946696 @default.
- W2020876082 cites W2054299066 @default.
- W2020876082 cites W2060239182 @default.
- W2020876082 cites W2064370832 @default.
- W2020876082 cites W2070858611 @default.
- W2020876082 cites W2077808864 @default.
- W2020876082 cites W2078298988 @default.
- W2020876082 cites W2082322888 @default.
- W2020876082 cites W2099534015 @default.
- W2020876082 cites W2104997591 @default.
- W2020876082 cites W2105573142 @default.
- W2020876082 cites W2111105929 @default.
- W2020876082 cites W2125510262 @default.
- W2020876082 cites W2142435309 @default.
- W2020876082 cites W2157118250 @default.
- W2020876082 cites W2170672898 @default.
- W2020876082 cites W2170880987 @default.
- W2020876082 cites W2190733500 @default.
- W2020876082 cites W4242942117 @default.
- W2020876082 doi "https://doi.org/10.1016/j.pnpbp.2008.03.015" @default.
- W2020876082 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18579280" @default.
- W2020876082 hasPublicationYear "2008" @default.
- W2020876082 type Work @default.
- W2020876082 sameAs 2020876082 @default.
- W2020876082 citedByCount "59" @default.
- W2020876082 countsByYear W20208760822012 @default.
- W2020876082 countsByYear W20208760822013 @default.
- W2020876082 countsByYear W20208760822014 @default.
- W2020876082 countsByYear W20208760822015 @default.
- W2020876082 countsByYear W20208760822016 @default.
- W2020876082 countsByYear W20208760822017 @default.
- W2020876082 countsByYear W20208760822018 @default.
- W2020876082 countsByYear W20208760822019 @default.
- W2020876082 countsByYear W20208760822020 @default.
- W2020876082 countsByYear W20208760822021 @default.
- W2020876082 countsByYear W20208760822022 @default.
- W2020876082 countsByYear W20208760822023 @default.
- W2020876082 crossrefType "journal-article" @default.
- W2020876082 hasAuthorship W2020876082A5012639651 @default.
- W2020876082 hasAuthorship W2020876082A5045766928 @default.
- W2020876082 hasAuthorship W2020876082A5046589366 @default.
- W2020876082 hasAuthorship W2020876082A5071471123 @default.
- W2020876082 hasAuthorship W2020876082A5086305216 @default.
- W2020876082 hasConcept C118552586 @default.
- W2020876082 hasConcept C126322002 @default.
- W2020876082 hasConcept C134018914 @default.
- W2020876082 hasConcept C2776412080 @default.
- W2020876082 hasConcept C2776619155 @default.
- W2020876082 hasConcept C2776921671 @default.
- W2020876082 hasConcept C2778999636 @default.
- W2020876082 hasConcept C2779357093 @default.
- W2020876082 hasConcept C2780057945 @default.
- W2020876082 hasConcept C2780221984 @default.
- W2020876082 hasConcept C2780494398 @default.
- W2020876082 hasConcept C2780613262 @default.
- W2020876082 hasConcept C2780864610 @default.
- W2020876082 hasConcept C511355011 @default.
- W2020876082 hasConcept C71315377 @default.
- W2020876082 hasConcept C71924100 @default.
- W2020876082 hasConceptScore W2020876082C118552586 @default.
- W2020876082 hasConceptScore W2020876082C126322002 @default.
- W2020876082 hasConceptScore W2020876082C134018914 @default.
- W2020876082 hasConceptScore W2020876082C2776412080 @default.
- W2020876082 hasConceptScore W2020876082C2776619155 @default.
- W2020876082 hasConceptScore W2020876082C2776921671 @default.
- W2020876082 hasConceptScore W2020876082C2778999636 @default.
- W2020876082 hasConceptScore W2020876082C2779357093 @default.
- W2020876082 hasConceptScore W2020876082C2780057945 @default.
- W2020876082 hasConceptScore W2020876082C2780221984 @default.
- W2020876082 hasConceptScore W2020876082C2780494398 @default.
- W2020876082 hasConceptScore W2020876082C2780613262 @default.
- W2020876082 hasConceptScore W2020876082C2780864610 @default.
- W2020876082 hasConceptScore W2020876082C511355011 @default.
- W2020876082 hasConceptScore W2020876082C71315377 @default.
- W2020876082 hasConceptScore W2020876082C71924100 @default.
- W2020876082 hasIssue "6" @default.
- W2020876082 hasLocation W20208760821 @default.
- W2020876082 hasLocation W20208760822 @default.
- W2020876082 hasOpenAccess W2020876082 @default.